China
· Delayed Price · Currency is CNY Pacific Shuanglin Bio-pharmacy Company Description
Pacific Shuanglin Bio-pharmacy Co., Ltd., together with its subsidiaries, engages in research, development, production, and sales of blood products in China and internationally.
The company offers human serum albumin, intravenous human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus and anti-tetanus human immunoglobulin, rabies patient immunoglobulin, human coagulation factor VIII, and human prothrombin complex; and freeze-dried intravenous human immunoglobulin (pH4), human fibrinogen, and intravenous hepatitis B human immunoglobulin (pH4).
In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; electronic product information consultation; trading; technology application; and technical services activities.
The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021.
Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is headquartered in Taiyuan, China.
| Country | China |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,635 |
| CEO | Xiankui Rong |
Contact Details
Address: Sunshine City Global Financial Center Taiyuan, 030000 China | |
| Phone | 86 75 9293 1218 |
| Website | slbiop.com |
Stock Details
| Ticker Symbol | 000403 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000F14 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Xiankui Rong | General Manager |
| Yehong Wang | Chief Financial Officer and Accounting Supervisor |
| Lei Yan | Deputy GM and Director |
| Wenbin Si | Deputy GM and Non-Independent Director |
| Xiaoying Huang | Deputy GM and Non-Independent Director |
| Lan Ye | Deputy GM and Non-Independent Director |
| Yulin Zhao | Board Secretary |